Novartis Czech Republic`s Total Revenue Growth reached -1.25 % in 2017. This is 107 % less than in the previous year.
Buy Total Revenue Growth data for Novartis Czech Republic.
$19.99Buy all data for Novartis Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 17.8 | -1.40 | 12.4 | 36.0 | -5.06 | |||||||
| Bayer Czech Republic | % | ... | ... | ... | -2.02 | -2.94 | 5.93 | 17.9 | 5.49 | |||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | -5.48 | -1.59 | -1.43 | -14.1 | -9.83 | |||||||||
| Merck Czech Republic | % | ... | ... | 17.9 | 8.18 | -1.61 | 4.15 | 2.88 | ||||||||||
| Novartis Czech Republic | % | 4.72 | -0.791 | 3.20 | 15.5 | 15.1 | ||||||||||||
| Pfizer Czech Republic | % | ... | ... | 4.32 | -54.2 | 73.4 | -8.51 | -36.9 | ||||||||||
| Roche Czech Republic | % | ... | ... | ... | -1.23 | -2.83 | 1.33 | -11.5 | 24.8 | ... | ||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | -6.44 | 2.62 | -9.60 | -6.30 | 7.77 | ||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 3.49 | 27.6 | 49.6 | ||
| Walmark | % | ... | ... | ... | -8.22 | -1.47 | -9.47 | 18.2 | -46.2 |
Helgi Library 
